S DavidMillerMD

PubMed

• 11 citations
  Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma.
  Dik Ng, Edward Kerwin, Martha V White, S. David Miller, Scott Haughie, Jonathan Ward, Richard Allan> ;Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2020 Apr 2
• 1 citations
  Randomized dose-ranging study of a budesonide metered-dose inhaler by using co-suspension delivery technology in asthma.
  S. David Miller, Jack Nyberg, Shahid Siddiqui, Paul Dorinsky, Earl St Rose, Colin Reisner> ;Allergy and Asthma Proceedings. 2018 Sep 23
• The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma.
  Erpenbeck, V. J., Erpenbeck, V. J., Erpenbeck, V. J., Erpenbeck, V. J., Popov, T. A., Popov, T. A., Popov, T. A., Popov, T. A., Miller, D., Miller, D., Miller, D., Mil...> ;Pulmonary pharmacology & therapeutics. 2016 Jun 30
• 5 citations
  Hypothalamic-Pituitary-Adrenal Axis Effects of Mometasone Furoate/Formoterol Fumarate vs Fluticasone Propionate/Salmeterol Administered Through Metered-Dose Inhaler
  Teddy Kosoglou, James Hubbell, David L. Cutler, Amy O. Johnson-Levonas, Danlin Xu, Bhavna Kantesaria, Kenneth Kim, S. David Miller> ;Chest. 2013 Dec 1
• 20 citations
  Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study
  C. LaForce, Glen E. Journeay, S. David Miller, Mary Jane Silvey, W. Wu, Laurie A. Lee, Leo T. Chylack> ;Annals of Allergy, Asthma & Immunology. 2013 Jul 1
• 99 citations
  Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies...
  Joseph M. Parker, Chad K. Oh, Craig LaForce, S. David Miller, David S. Pearlman, Chenxiong Le, Gabriel Robbie, Wendy I. White, Barbara White, Nestor A. Molfino> ;BMC Pulmonary Medicine. 2011 Feb 28
• 21 citations
  Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics
  Stephen B. Shrewsbury, Shashidhar Kori, S. David Miller, Andrew Pedinoff, Steven Weinstein> ;Current Medical Research and Opinion. 2008 Jun 4
• 63 citations
  Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.
  James P. Kemp, Robert B. Berkowitz, S. David Miller, John J. Murray, Keith Nolop, Judy E. Harrison> ;The Journal of Allergy and Clinical Immunology. 2000 Sep 1
• Join now to see all